1. Cell Cycle/DNA Damage Cytoskeleton
  2. Microtubule/Tubulin
  3. Tubulin inhibitor 25

Tubulin inhibitor 25 is a potent tubulin inhibitor with an IC50 value of 0.98 μM. Tubulin inhibitor 25 exhibits remarkable activity against cancer cell line HT29. Tubulin inhibitor 25 displays the potent inhibition on cell migration and tube formation that contributes to the anti-angiogenesis.

For research use only. We do not sell to patients.

Tubulin inhibitor 25 Chemical Structure

Tubulin inhibitor 25 Chemical Structure

CAS No. : 2411697-71-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Tubulin inhibitor 25 is a potent tubulin inhibitor with an IC50 value of 0.98 μM. Tubulin inhibitor 25 exhibits remarkable activity against cancer cell line HT29. Tubulin inhibitor 25 displays the potent inhibition on cell migration and tube formation that contributes to the anti-angiogenesis[1].

IC50 & Target

IC50: 0.98 μM (tubulin)[1]

In Vitro

Tubulin inhibitor 25 (compound 6c) (0-100 μM; 48 hours) exhibits high antiproliferative activity against tested cancer cell lines[1].
Tubulin inhibitor 25 (0-200 μM; 48 hours) exhibits low cytotoxicity in normal cell lines[1].
Tubulin inhibitor 25 (0.05, 0.1 and 0.2 μM; 24 hours) inhibits the colony formation of HT29 cells in a dose-dependent manner[1].
Tubulin inhibitor 25 (2 and 4 μM) can inhibit the tubulin polymerization and compete with colchicine binding site[1].
Tubulin inhibitor 25 (0.25-1 μM; 12-48 hours) arrests the cell cycle at G2/M phase and induces HT29 cells apoptosis in a dose- and time-dependent manner, besides induces HT29 cell depolarized mitochondria in the process of apoptosis[1].
Tubulin inhibitor 25 (0.25-1 μM; 24 hours) increases the expression of P21 and Cyclin B1 and decreases the expression of Cdc2, p-CDC2 and p-Cdc25c; as well as induces the microtubule collapse in HT29 cells in a dose-dependent manner[1].
Tubulin inhibitor 25 (0.01, 0.02 and 0.04 μM; 6 hours) effectively inhibits the HUVEC tube formation in a dose-dependent manner[1].
Tubulin inhibitor 25 (0.1, 0.2 and 0.4 μM; 24 hours) inhibits migration of A549 cells in a dose-dependent manner[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay

Cell Line: MDA-MB-231, HepG2, HT29, HCT116 and A549[1]
Concentration: 0-100 μM
Incubation Time: 48 hours
Result: Exhibited high antiproliferative activity against HT29, HCT116, MDA-MB-231 and A549 with IC50s of 0.18 ± 0.04 μM, 0.58 ± 0.11 μM, 0.81 ± 0.13 μM and 0.57 ± 0.79 μM, and less activity against HepG2 with an IC50 of 73.20 ± 4.03 μM.

Cell Cytotoxicity Assay

Cell Line: 293T and LO2[1]
Concentration: 0-200 μM
Incubation Time: 48 hours
Result: Exhibited low cytotoxicity in normal cell lines with CC50s of 184.86 ± 9.88 μM and 154.76 ± 9.98 μM in 293T and LO2.

Cell Cycle Analysis

Cell Line: HT29[1]
Concentration: 0.25, 0.5 and 1 μM
Incubation Time: 12, 24, 36 and 48 hours
Result: Arrested the cell cycle at G2/M phase in a dose-dependent manner with the G2/M cell proportion of 23.05%, 23.55% and 80.99% at 0.25 μM, 0.5 μM and 1 μM, respectively, also exhibited time-dependent manner with the G2/M cell proportion of 32.55%, 36.43% and 71.1% for 12, 36 and 48 hours.

Western Blot Analysis

Cell Line: HT29[1]
Concentration: 0.25, 0.5 and 1 μM
Incubation Time: 24 hours
Result: Increased the expression of P21 and Cyclin B1 and decreased the expression of Cdc2, p-CDC2 and p-Cdc25c.
In Vivo

Tubulin inhibitor 25 (1.5 mg/kg; IV; single) exhibits good metabolic stability[1].
Pharmacokinetic Parameters of Tubulin inhibitor 25 in male Sprague-Dawley rats[1].

IV (1.5 mg/kg)
T1/2 (h) 3.81 ± 2.14
MRT0-∞ (h) 5.12 ± 2.86
AUC0-∞ (ng/mL·h) 2156.12 ± 851.88
VZ (L/kg) 3.348 ± 0.734

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SD rats[1]
Dosage: 1.5 mg/kg
Administration: IV; single (Pharmacokinetic Analysis)
Result: Exhibited good metabolic stability.
Molecular Weight

462.45

Formula

C26H22O8

CAS No.
SMILES

O=C(C1=CC2=CC=CC(OC)=C2O1)O[C@@H](C(C3=O)=CC(C4=C3C(O)=CC=C4O)=O)C/C=C(C)/C

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Tubulin inhibitor 25
Cat. No.:
HY-146778
Quantity:
MCE Japan Authorized Agent: